What is the main business of Medialis Pharm?

The main business activity of Medialis Pharm focuses on activities of head office and holding companies, excluding financial holding companies.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 14, 2010.

Where is the headquarters located?

The headquarters is located at: Baczyńskiego 12, 41-203 Sosnowiec.

Who is on the management board?

The management board consists of: Marcin Piotr Bojarski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 4,921,350 (approx. $1.3 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $4,219,703 in 2024, which is an increase of 19.8% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $109,978, meaning the company decreased its profit by 0.4%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $2,902,345 in 2024, representing 73% of all operating expenses.

Medialis Pharmsp. z o.o.

Activities of head office and holding companies, excluding financial holding companies

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2010-12-14

Share capital

4 921 350,00 PLN

Registered address

Baczyńskiego 12, 41-203 Sosnowiec, Poland

Electronic delivery address

AE:PL-68746-67174-BECIT-21

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 4.22mMedianUSD 24.61kAverageUSD 4.55m

Net profit

This companyUSD -77.36kMedianUSD 231.37AverageUSD 680.87k

Operating costs

This companyUSD 4.15mMedianUSD 10.95kAverageUSD 3.40m

Assets

This companyUSD 2.99mMedianUSD 81.83kAverageUSD 15.29m

Industry

Bank accounts

Registered as a VAT taxpayer on 2017-02-13. Active

mBank
19 1140 0026 0000 3570 6900 1001
Bank Pekao SA
52 1240 6292 1111 0010 7734 2385
Bank Pekao SA
63 1240 6292 1111 0010 7734 2284

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

5 public aid cases recorded, with a total value of $142,254.

Grant date	Purpose	Gross amount	Granting body
Sep 16, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	$21,138$21,138	Prezes Banku Gospodarstwa Krajowego
Sep 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$5,307$5,307	Prezes Zakładu Ubezpieczeń Społecznych
Sep 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$4,806$4,806	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

National Health Fund (NFZ) contracts

Medialis Pharm has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of care	NFZ branch	Contracts	Value in 2026
Inne usługi realizowane w aptekach	śląskie	1	USD 0.00

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Marcin Piotr Bojarski – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board acts independently. In the case of a multi-member management board, two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy, act.

Ownership

Owner	Shares	Share value	Stake
Cosmedica sp. z o.o.	96,460	$1,302,809.29	98.0016%
Others	1,967	$26,566.72	1.9984%

Beneficial owners

Person	Rights
Kazimierz Janusz Napiórkowski (56)	100% udziałów w cosmedica sp. z o. o. wspólniku spółki

Competitors

Name	Revenue	Website
ZMB Capitalsp. z o.o.	$7,848,699.03	zmbcapital.pl
Boryszew Automotive Plasticssp. z o.o.	$7,266,951.28	bap.boryszew.eu
Virtu Holdingsp. z o.o.	$3,239,326.97	virtu.com.pl
Centrum Naukowo-Przemysłowe EmagS.A.	$2,171,043.15	cnp-emag.pl
Holding WilkS.K.A.	$568,193.68	holdingwilk.wordpress.com
Ignis Avem CapitalS.A.	$429,662.61	ignisavem.com
Berg HoldingS.A.	$311,509.33	bergholding.pl
Maxitosp. z o.o.	$160,842.07	maxito.pl
Xool.Plsp. z o.o.	$117,218.91	xool.pl
Thorliningssp. z o.o.	$52,755.85	thorlinings.com

Change history

Date	Event
2017-03-07	Share capital change (5,000.00 PLN → 4,921,350.00 PLN)
2015-10-27	PKD change (Removed: 20.59.Z, 26.11.Z, 32.50.Z, 41.20.Z, 42.21.Z, 42.22.Z, 42.99.Z, 43.21.Z, 43.22.Z, 43.29.Z, 43.31.Z, 43.32.Z, 43.33.Z, 43.34.Z, 43.39.Z, 43.91.Z, 43.99.Z, 47.21.Z, 47.29.Z, 58.2, 62.02.Z, 64.20.Z, 64.30.Z, 64.92.Z, 64.99.Z, 66.12.Z, 66.19.Z, 66.21.Z, 66.22.Z, 66.29.Z, 68.10.Z, 68.20.Z, 68.31.Z, 68.32.Z, 69.20.Z, 70, 71.11.Z, 71.12.Z, 73.11.Z, 73.12.B, 73.12.C, 73.12.D, 74.90.Z, 77, 79.11.B, 79.12.Z, 81.10.Z, 81.21.Z, 81.22.Z, 81.29.Z, 82.91.Z, 82.99.Z, 85.60.Z; Added: 70.10.Z)
2014-01-31	Address change (Kilińskiego 34/28, 41-200, Sosnowiec → Baczyńskiego 12, 41-203, Sosnowiec)
2014-01-31	Name change (Medialis Ii → Medialis Pharm)
2010-12-14	Entered in the register

FAQ

Last updated: 2026-07-15